Q3 2026 lobbying Ended · Cassidy Filed Oct 20
Q3 spend$270KQ2 $290K
QoQ−6.9%vs Q2 2026
YoY−18.2%vs Q3 2025
AgenciesCongress onlyHouse, Senate
HCRHealth Issues
Lobbied on Telehealth; access to compounded drugs and drug shortages
Bills H.R. 6509SAFE Drugs Act of 2025 In committeeS. 3794SAFE Drugs Act of 2026 In committee
No member trades in 90 days Stock page ›